MYO
Myomo·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 3
Stock Price Surged Significantly
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
RSI Overbought
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MYO
Myomo, Inc.
A wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis
Healthcare Equipment and Supplies
09/01/2004
06/12/2017
American Stock Exchange
184
12-31
Common stock
137 Portland St, 4th Floor, Boston, Massachusetts 02114
--
Myomo, Inc., was incorporated in Delaware on September 1, 2004. The company is a medical robotics company that develops, designs and produces electromyography orthotics for patients with neuromuscular disorders. MyoPro EMG upper limb orthosis products are registered as Class I medical devices with the Food and Drug Administration. Myomo is a patent licensor for a technology-based EMG limb orthosis patent developed by MIT in collaboration with medical experts affiliated with Harvard Medical School. The company's equipment is currently used by patients in leading rehabilitation facilities, including the Mayo Clinic, Cleveland Clinic, Walter Reed National Military Medical Center and VA hospitals across the country.
Earnings Call
Q1/2025
Estimate EPS-0.08
Actual EPS-0.08
Estimate Revenue9.22M
Actual Revenue9.80M
Myomo's Q1 2025: Navigating Contradictions in Advertising Efficiency, Margins, and Revenue Growth
May 08,2025 07:33
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS-0.11
Actual EPS-0.09
Estimate Revenue9.44M
Actual Revenue10.10M
Myomo's Q3 2025: Contradictions Emerge on Pipeline Growth, Authorizations, Customer Acquisition Costs, Orthotist Expansion, and Breakeven Timelines
Nov 10,2025 10:57
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
MYO has released its 2025 Q3 earnings. EPS was reported at -0.09, versus the expected -0.11, beating expectations. The chart below visualizes how MYO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MYO has released its 2025 Q3 earnings report, with revenue of 10.09M, reflecting a YoY change of 9.59%, and net profit of -3.66M, showing a YoY change of -279.02%. The Sankey diagram below clearly presents MYO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
